Immunocore announces strategic priorities at 43rd Annual J.P. Morgan Healthcare Conference
Reaching more mUM patients globally with KIMMTRAK (tebentafusp) in 2025 through additional launches and increased community penetrationEnrolling ...
Marengo Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Marengo Therapeutics, Inc., a clinical-stage biotechnology company pioneering novel approaches for precision T cell activation, today announced that Zhen Su, M.D., MBA, the Company's Chief Executive ...
F1 Chronicle on MSN6d
How Fast Is A Formula 1 Car?
Have you ever asked yourself ‘how fast is a Formula 1 car?’ especially in relation to other categories? Speed is the key ...
Le Lézard3d
Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate updates and ...
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
Intensity Therapeutics, Inc. ("Intensity" or the "Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the discovery and development of proprietary, novel immune-based ...
eLife4d
Aurora kinase A promotes trained immunity via regulation of endogenous S-adenosylmethionine metabolism
MOE Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen ...